- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05544708
Using Grassroots Wellness Coaching to Enhance Reach and Sustainability of Behavioral Weight Management
Using Grassroots Wellness Coaching to Enhance Reach and Sustainability of Behavioral Weight Management-Phase I
African American adults that live in economically disadvantaged areas are at an increased risk for obesity and cardiometabolic disease. The program being tested in this research study aims to address these factors and increase outcomes for the study population. The purpose of this research study is to find out about the feasibility and acceptability of using house chats (HC) as a model for delivering a weight-management program in a real-world, community-based setting.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Wellness Ambassadors will undergo training to recruit and deliver a lifestyle intervention to members of their social networks.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Virginia
-
Richmond, Virginia, United States, 23298
- Virginia Commonwealth University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 and older
- Resident of Petersburg, VA
- Interested in engaging community members in healthy lifestyle changes (e.g., walking, small changes to eating) and willing to engage in these behaviors her/himself
Exclusion Criteria:
- A diagnosis of type 1 diabetes mellitus.
- Currently being treated for cancer.
- Medical conditions that may increase risk for participating in unsupervised exercise, if medical clearance is not provided
- Hospitalization for depression or other psychiatric disorder within the past 12 months.
- Lifetime history of bipolar disorder or psychotic disorder.
- Currently pregnant or lactating, or planning to become pregnant within the study period.
- Current involvement in a weight loss program or current use of weight loss medication.
- Inability to speak, read and write English.
- Planning to move from the Petersburg area within the study period.
- Does not have sufficient numbers of individuals in their social network from which to recruit for the proposed study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Wellness Ambassadors will undergo training to recruit and deliver a lifestyle intervention to members of their social networks. HCL in the intervention group will deliver the intervention immediately following baseline visits and randomization. |
Train for, recruit participants into, and lead a 12-week lifestyle intervention delivered via weekly group meetings |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feasibility: House Chat Leaders (HCL)
Time Frame: 18 months
|
House Chat Leaders (HCL) will undergo training to recruit and deliver a lifestyle intervention to members of their social networks. |
18 months
|
|
Feasibility: Participants
Time Frame: 18 months
|
The total number of participants recruited by the HCLs. The pre-specified goal is 80 participants overall (approximately 8 per house chat). A total of 71 individuals were interested and completed initial pre-screening. Of those, 43 were eligible and consented to participate. One individual did not complete their baseline visit, leaving 42 participants randomization eligible. |
18 months
|
|
Feasibility: Delivery Model
Time Frame: 12 weeks
|
The number of intervention sessions delivered as planned. The pre-specified threshold was 70% of sessions. |
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability: Attendance
Time Frame: 12 weeks
|
The average number of sessions attended by participants. The pre-specified threshold was 70% of sessions. |
12 weeks
|
|
Acceptability: Retention
Time Frame: 12 weeks
|
The percentage of participants who are retained in the program. The pre-specified target to demonstrate acceptability was 80% retention. |
12 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Moghboeba Mosavel, PhD, Virginia Commonwealth University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HM20024014
- 1R01DK132373 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.